Clinical trials
Polyneuropathies trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 3 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Pfizer | 3 |
| Baxalta now part of Shire | 1 |
| Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | 1 |
| Centre Hospitalier Régional d'Orléans | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Erasmus Medical Center | 1 |
| Institut Mutualiste Montsouris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polyneuropathies | 18 |
| Amyloidosis | 9 |
| Amyloid Neuropathies, Familial | 6 |
| Alzheimer Disease | 3 |
| Amyloidosis, Familial | 2 |
| Autoimmune Diseases | 2 |
| Cardiomyopathies | 2 |
| Immune System Diseases | 2 |
| Neuromuscular Diseases | 2 |
| Peripheral Nervous System Diseases | 2 |
Trials
Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.